RAN-GABAPENTIN (2015-04-10)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type I
| Lot or serial number | Companies | Brand name | Dosage form | DIN, NPN, DIN-HIM | Strength |
|---|
| 2582026 | - Recalling Firm
- Ranbaxy Pharmaceuticals Canada Inc.
- 200-2680 Matheson Blvd. East
- Mississauga
- L4W 0A5
- Ontario
- CANADA
- Marketing Authorization Holder
- Ranbaxy Pharmaceuticals Canada Inc.
- 200-2680 Matheson Blvd. East
- Mississauga
- L4W 0A5
- Ontario
- CANADA
| RAN-Gabapentin | Capsule | DIN 02319055 | Gabapentin 100 mg |
Recalled Products
RAN-Gabapentin
Possibility of contamination with trace amounts of the active ingredient Etodolac.